Lazo, A.; de la Torre-Luque, A.; Arregui, G.; Rivas, D.; Serradilla, A.; Gómez, J.; Jurado, F.; Núñez, M.I.; López, E.
Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer. Biology 2022, 11, 435.
https://doi.org/10.3390/biology11030435
AMA Style
Lazo A, de la Torre-Luque A, Arregui G, Rivas D, Serradilla A, Gómez J, Jurado F, Núñez MI, López E.
Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer. Biology. 2022; 11(3):435.
https://doi.org/10.3390/biology11030435
Chicago/Turabian Style
Lazo, Antonio, Alejandro de la Torre-Luque, Gregorio Arregui, Daniel Rivas, Ana Serradilla, Joaquin Gómez, Francisca Jurado, MarÃa Isabel Núñez, and Escarlata López.
2022. "Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer" Biology 11, no. 3: 435.
https://doi.org/10.3390/biology11030435
APA Style
Lazo, A., de la Torre-Luque, A., Arregui, G., Rivas, D., Serradilla, A., Gómez, J., Jurado, F., Núñez, M. I., & López, E.
(2022). Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer. Biology, 11(3), 435.
https://doi.org/10.3390/biology11030435